Migraine is a widespread neurological condition that disproportionately impacts women, particularly those between the ages of 20 and 50 [2].
This disparity highlights a critical gap in healthcare recognition, as the condition often causes significant disability but remains frequently dismissed by providers and society [1, 2].
More than 1 billion people worldwide are affected by migraine [3]. While the condition impacts all genders, the prevalence ratio changes significantly after puberty. In this stage of life, migraines are about three to four times higher in women than in men [2].
Neurologist Dr. Vanessa Doyle said the condition is a common neurological disorder that often goes under-recognized [1]. The impact is most pronounced for women in their prime working and caregiving years, specifically those aged 20 to 50 [2].
Despite the high volume of cases, many women report that their symptoms are minimized. This dismissiveness can lead to delays in proper diagnosis and treatment, extending the period of pain and disability for millions of patients globally [1, 2].
Medical experts emphasize that migraine is not merely a headache but a complex neurological event. Because it affects such a large portion of the global population, increasing awareness of gender-specific prevalence is essential for improving patient outcomes [3].
“Migraines are about three to four times higher in women than in men after puberty.”
The high prevalence of migraines among women of reproductive and mid-life age suggests a strong link between neurological health and biological factors. The fact that the condition is frequently dismissed despite affecting over a billion people indicates a systemic failure in how chronic pain is validated in women, potentially leading to long-term economic and social disability.
